1 |
|
PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling
|
135 |
2.026 |
SuperPathway |
- PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling
|
Genes names |
- AKT Serine/Threonine Kinase 1
- AKT Serine/Threonine Kinase 2
- AKT Serine/Threonine Kinase 3
|
Pathways |
- Negative regulation of the PI3K/AKT network
- PI5P, PP2A and IER3 Regulate PI3K/AKT Signaling
- PI3K/AKT Signaling in Cancer
|
|
2 |
|
PI3K-Akt signaling pathway
|
390 |
1.990 |
SuperPathway |
- PI3K-Akt signaling pathway
|
Genes names |
- AKT Serine/Threonine Kinase 1
- AKT Serine/Threonine Kinase 2
- AKT Serine/Threonine Kinase 3
- TCL1 Family AKT Coactivator A
- TCL1 Family AKT Coactivator B
|
Pathways |
- PI3K-Akt signaling pathway
- Focal adhesion: PI3K-Akt-mTOR-signaling pathway
|
|
3 |
|
PI3K / Akt Signaling
|
92 |
1.700 |
SuperPathway |
|
Genes names |
- AKT Serine/Threonine Kinase 1
- AKT Serine/Threonine Kinase 2
- AKT Serine/Threonine Kinase 3
- TCL1 Family AKT Coactivator A
|
Pathways |
|
|
4 |
|
PIP3 activates AKT signaling
|
310 |
1.627 |
SuperPathway |
- PIP3 activates AKT signaling
|
Genes names |
- AKT Serine/Threonine Kinase 1
- AKT Serine/Threonine Kinase 2
- AKT Serine/Threonine Kinase 3
|
Pathways |
- PIP3 activates AKT signaling
|
|
5 |
|
Akt Signaling
|
682 |
1.627 |
SuperPathway |
|
Genes names |
- AKT Serine/Threonine Kinase 1
- AKT Serine/Threonine Kinase 2
- AKT Serine/Threonine Kinase 3
|
Pathways |
|
|
6 |
|
Constitutive Signaling by AKT1 E17K in Cancer
|
38 |
1.563 |
Genes names |
- AKT Serine/Threonine Kinase 1
- AKT Serine/Threonine Kinase 2
- AKT Serine/Threonine Kinase 3
|
Pathways |
- AKT phosphorylates targets in the nucleus
- Class I PI3K signaling events mediated by Akt
- AKT phosphorylates targets in the cytosol
- AKT-mediated inactivation of FOXO1A
|
|
7 |
|
PI3K-AKT-mTOR signaling pathway and therapeutic opportunities
|
30 |
1.427 |
SuperPathway |
- PI3K-AKT-mTOR signaling pathway and therapeutic opportunities
|
Genes names |
- AKT Serine/Threonine Kinase 1
|
Pathways |
- PI3K-AKT-mTOR signaling pathway and therapeutic opportunities
|
|
8 |
|
Modulation of PI3K-Akt-mTOR signaling by bioactive sphingolipids
|
7 |
1.427 |
SuperPathway |
- Modulation of PI3K-Akt-mTOR signaling by bioactive sphingolipids
|
Genes names |
- AKT Serine/Threonine Kinase 1
|
Pathways |
- Modulation of PI3K-Akt-mTOR signaling by bioactive sphingolipids
|
|
9 |
|
PI3K/AKT/mTOR - vitamin D3 signaling
|
22 |
1.427 |
SuperPathway |
- PI3K/AKT/mTOR - vitamin D3 signaling
|
Genes names |
- AKT Serine/Threonine Kinase 1
|
Pathways |
- PI3K/AKT/mTOR - vitamin D3 signaling
|
|
10 |
|
Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling
|
36 |
1.427 |
SuperPathway |
- Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling
|
Genes names |
- AKT Serine/Threonine Kinase 1
|
Pathways |
- Factors and pathways affecting insulin-like growth factor (IGF1)-Akt signaling
|
|
11 |
|
Autophagy pathway
|
228 |
1.091 |
Genes names |
- AKT Serine/Threonine Kinase 1
- AKT Serine/Threonine Kinase 2
- AKT Serine/Threonine Kinase 3
- AKT Interacting Protein
|
Pathways |
|
|
12 |
|
MAPK Signaling: Mitogens
|
108 |
1.018 |
Genes names |
- AKT Serine/Threonine Kinase 1
- AKT Serine/Threonine Kinase 2
- AKT Serine/Threonine Kinase 3
|
Pathways |
|
|
13 |
|
CD28 co-stimulation
|
119 |
1.018 |
Genes names |
- AKT Serine/Threonine Kinase 1
- AKT Serine/Threonine Kinase 2
- AKT Serine/Threonine Kinase 3
|
Pathways |
- CD28 dependent PI3K/Akt signaling
|
|
14 |
|
Development IGF-1 receptor signaling
|
110 |
1.018 |
Genes names |
- AKT Serine/Threonine Kinase 1
- AKT Serine/Threonine Kinase 2
- AKT Serine/Threonine Kinase 3
|
Pathways |
- Signal transduction AKT signaling
|
|
15 |
|
NF-kappaB Pathway
|
152 |
1.018 |
Genes names |
- AKT Serine/Threonine Kinase 1
- AKT Serine/Threonine Kinase 2
- AKT Serine/Threonine Kinase 3
|
Pathways |
|
|
16 |
|
Translation Insulin regulation of translation
|
183 |
1.018 |
Genes names |
- AKT Serine/Threonine Kinase 1
- AKT Serine/Threonine Kinase 2
- AKT Serine/Threonine Kinase 3
|
Pathways |
- Development Growth hormone signaling via PI3K/AKT and MAPK cascades
|
|
17 |
|
AMP-activated protein kinase signaling
|
100 |
0.546 |
Genes names |
- AKT Serine/Threonine Kinase 1
- AKT Serine/Threonine Kinase 2
- AKT Serine/Threonine Kinase 3
- AKT Interacting Protein
|
|
18 |
|
B Cell Receptor Signaling Pathway
|
148 |
0.546 |
Genes names |
- AKT Serine/Threonine Kinase 1
- AKT Serine/Threonine Kinase 2
- AKT Serine/Threonine Kinase 3
- AKT Interacting Protein
|
|
19 |
|
Signaling events mediated by TCPTP
|
39 |
0.545 |
Pathways |
- MET activates PI3K/AKT signaling
|
|
20 |
|
Signaling by NTRKs
|
134 |
0.545 |
|
21 |
|
Rab regulation of trafficking
|
124 |
0.473 |
Genes names |
- AKT Serine/Threonine Kinase 1
- AKT Serine/Threonine Kinase 2
- AKT Serine/Threonine Kinase 3
|
|
22 |
|
Beta-Adrenergic Signaling
|
333 |
0.473 |
Genes names |
- AKT Serine/Threonine Kinase 1
- AKT Serine/Threonine Kinase 2
- AKT Serine/Threonine Kinase 3
|
|
23 |
|
Acute myeloid leukemia
|
66 |
0.473 |
Genes names |
- AKT Serine/Threonine Kinase 1
- AKT Serine/Threonine Kinase 2
- AKT Serine/Threonine Kinase 3
|
|
24 |
|
Programmed Cell Death
|
213 |
0.473 |
Genes names |
- AKT Serine/Threonine Kinase 1
- AKT Serine/Threonine Kinase 2
- AKT Serine/Threonine Kinase 3
|
|
25 |
|
Gene expression (Transcription)
|
1546 |
0.473 |
Genes names |
- AKT Serine/Threonine Kinase 1
- AKT Serine/Threonine Kinase 2
- AKT Serine/Threonine Kinase 3
|
|
26 |
|
Development_Leptin signaling via PI3K-dependent pathway
|
52 |
0.473 |
Genes names |
- AKT Serine/Threonine Kinase 1
- AKT Serine/Threonine Kinase 2
- AKT Serine/Threonine Kinase 3
|
|
27 |
|
Small cell lung cancer
|
96 |
0.473 |
Genes names |
- AKT Serine/Threonine Kinase 1
- AKT Serine/Threonine Kinase 2
- AKT Serine/Threonine Kinase 3
|
|
28 |
|
TCR Signaling (Qiagen)
|
238 |
0.473 |
Genes names |
- AKT Serine/Threonine Kinase 1
- AKT Serine/Threonine Kinase 2
- AKT Serine/Threonine Kinase 3
|
|
29 |
|
Immune response Fc epsilon RI pathway
|
129 |
0.473 |
Genes names |
- AKT Serine/Threonine Kinase 1
- AKT Serine/Threonine Kinase 2
- AKT Serine/Threonine Kinase 3
|
|
30 |
|
NRP1-triggered signaling pathways in pancreatic cancer
|
53 |
0.473 |
Genes names |
- AKT Serine/Threonine Kinase 1
- AKT Serine/Threonine Kinase 2
- AKT Serine/Threonine Kinase 3
|
|
31 |
|
Development VEGF signaling via VEGFR2 - generic cascades
|
147 |
0.473 |
Genes names |
- AKT Serine/Threonine Kinase 1
- AKT Serine/Threonine Kinase 2
- AKT Serine/Threonine Kinase 3
|
|
32 |
|
Alzheimer's disease and miRNA effects
|
267 |
0.473 |
Genes names |
- AKT Serine/Threonine Kinase 1
- AKT Serine/Threonine Kinase 2
- AKT Serine/Threonine Kinase 3
|
|
33 |
|
Cytoskeleton remodeling Regulation of actin cytoskeleton by Rho GTPases
|
187 |
0.473 |
Genes names |
- AKT Serine/Threonine Kinase 1
- AKT Serine/Threonine Kinase 2
- AKT Serine/Threonine Kinase 3
|
|
34 |
|
Death Receptor Signaling Pathway
|
119 |
0.473 |
Genes names |
- AKT Serine/Threonine Kinase 1
- AKT Serine/Threonine Kinase 2
- AKT Serine/Threonine Kinase 3
|
|
35 |
|
Signaling by Overexpressed Wild-Type EGFR in Cancer
|
24 |
0.473 |
Genes names |
- AKT Serine/Threonine Kinase 1
- AKT Serine/Threonine Kinase 2
- AKT Serine/Threonine Kinase 3
|
|
36 |
|
Transcription_NF-kB signaling pathway
|
54 |
0.473 |
Genes names |
- AKT Serine/Threonine Kinase 1
- AKT Serine/Threonine Kinase 2
- AKT Serine/Threonine Kinase 3
|
|
37 |
|
Signaling by Receptor Tyrosine Kinases
|
524 |
0.473 |
Genes names |
- AKT Serine/Threonine Kinase 1
- AKT Serine/Threonine Kinase 2
- AKT Serine/Threonine Kinase 3
|
|
38 |
|
G-protein signaling_Cross-talk between Ras-family GTPases
|
24 |
0.473 |
Genes names |
- AKT Serine/Threonine Kinase 1
- AKT Serine/Threonine Kinase 2
- AKT Serine/Threonine Kinase 3
|
|
39 |
|
CTNNB1 S33 mutants aren't phosphorylated
|
58 |
0.473 |
Genes names |
- AKT Serine/Threonine Kinase 1
- AKT Serine/Threonine Kinase 2
- AKT Serine/Threonine Kinase 3
|
|
40 |
|
Breast cancer pathway
|
199 |
0.473 |
Genes names |
- AKT Serine/Threonine Kinase 1
- AKT Serine/Threonine Kinase 2
- AKT Serine/Threonine Kinase 3
|
|
41 |
|
VEGF Pathway (Tocris)
|
58 |
0.473 |
Genes names |
- AKT Serine/Threonine Kinase 1
- AKT Serine/Threonine Kinase 2
- AKT Serine/Threonine Kinase 3
|
|
42 |
|
Integrin-mediated cell adhesion
|
140 |
0.473 |
Genes names |
- AKT Serine/Threonine Kinase 1
- AKT Serine/Threonine Kinase 2
- AKT Serine/Threonine Kinase 3
|
|
43 |
|
PAK Pathway
|
686 |
0.473 |
Genes names |
- AKT Serine/Threonine Kinase 1
- AKT Serine/Threonine Kinase 2
- AKT Serine/Threonine Kinase 3
|
|
44 |
|
MAPK signaling pathway
|
244 |
0.473 |
Genes names |
- AKT Serine/Threonine Kinase 1
- AKT Serine/Threonine Kinase 2
- AKT Serine/Threonine Kinase 3
|
|
45 |
|
TGF-beta Signaling Pathways
|
96 |
0.473 |
Genes names |
- AKT Serine/Threonine Kinase 1
- AKT Serine/Threonine Kinase 2
- AKT Serine/Threonine Kinase 3
|
|
46 |
|
mTOR Signaling
|
139 |
0.473 |
Genes names |
- AKT Serine/Threonine Kinase 1
- AKT Serine/Threonine Kinase 2
- AKT Serine/Threonine Kinase 3
|
|
47 |
|
Apoptosis and survival FAS signaling cascades
|
108 |
0.473 |
Genes names |
- AKT Serine/Threonine Kinase 1
- AKT Serine/Threonine Kinase 2
- AKT Serine/Threonine Kinase 3
|
|
48 |
|
Hepatocyte growth factor receptor signaling
|
115 |
0.473 |
Genes names |
- AKT Serine/Threonine Kinase 1
- AKT Serine/Threonine Kinase 2
- AKT Serine/Threonine Kinase 3
|
|
49 |
|
NGF Pathway
|
87 |
0.473 |
Genes names |
- AKT Serine/Threonine Kinase 1
- AKT Serine/Threonine Kinase 2
- AKT Serine/Threonine Kinase 3
|
|
50 |
|
JAK-STAT signaling in the regulation of Beta-cells
|
35 |
0.473 |
Genes names |
- AKT Serine/Threonine Kinase 1
- AKT Serine/Threonine Kinase 2
- AKT Serine/Threonine Kinase 3
|
|
51 |
|
Endometrial cancer
|
201 |
0.473 |
Genes names |
- AKT Serine/Threonine Kinase 1
- AKT Serine/Threonine Kinase 2
- AKT Serine/Threonine Kinase 3
|
|
52 |
|
Cellular responses to stimuli
|
802 |
0.473 |
Genes names |
- AKT Serine/Threonine Kinase 1
- AKT Serine/Threonine Kinase 2
- AKT Serine/Threonine Kinase 3
|
|
53 |
|
fMLP Pathway
|
266 |
0.473 |
Genes names |
- AKT Serine/Threonine Kinase 1
- AKT Serine/Threonine Kinase 2
- AKT Serine/Threonine Kinase 3
|
|
54 |
|
CCR5 Pathway in Macrophages
|
321 |
0.473 |
Genes names |
- AKT Serine/Threonine Kinase 1
- AKT Serine/Threonine Kinase 2
- AKT Serine/Threonine Kinase 3
|
|
55 |
|
Regulation of TP53 Activity
|
362 |
0.473 |
Genes names |
- AKT Serine/Threonine Kinase 1
- AKT Serine/Threonine Kinase 2
- AKT Serine/Threonine Kinase 3
|
|
56 |
|
Defective binding of RB1 mutants to E2F1,(E2F2, E2F3)
|
88 |
0.473 |
Genes names |
- AKT Serine/Threonine Kinase 1
- AKT Serine/Threonine Kinase 2
- AKT Serine/Threonine Kinase 3
|
|
57 |
|
CD28 Signaling in T-Helper Cell
|
113 |
0.473 |
Genes names |
- AKT Serine/Threonine Kinase 1
- AKT Serine/Threonine Kinase 2
- AKT Serine/Threonine Kinase 3
|
|
58 |
|
Development Angiotensin activation of ERK
|
225 |
0.473 |
Genes names |
- AKT Serine/Threonine Kinase 1
- AKT Serine/Threonine Kinase 2
- AKT Serine/Threonine Kinase 3
|
|
59 |
|
Mitotic G1 phase and G1/S transition
|
149 |
0.473 |
Genes names |
- AKT Serine/Threonine Kinase 1
- AKT Serine/Threonine Kinase 2
- AKT Serine/Threonine Kinase 3
|
|
60 |
|
ERK Signaling
|
1185 |
0.473 |
Genes names |
- AKT Serine/Threonine Kinase 1
- AKT Serine/Threonine Kinase 2
- AKT Serine/Threonine Kinase 3
|
|
61 |
|
Notch Signaling Pathways
|
100 |
0.473 |
Genes names |
- AKT Serine/Threonine Kinase 1
- AKT Serine/Threonine Kinase 2
- AKT Serine/Threonine Kinase 3
|
|
62 |
|
Vesicle-mediated transport
|
673 |
0.473 |
Genes names |
- AKT Serine/Threonine Kinase 1
- AKT Serine/Threonine Kinase 2
- AKT Serine/Threonine Kinase 3
|
|
63 |
|
Immune response CCR3 signaling in eosinophils
|
146 |
0.473 |
Genes names |
- AKT Serine/Threonine Kinase 1
- AKT Serine/Threonine Kinase 2
- AKT Serine/Threonine Kinase 3
|
|
64 |
|
Proteolysis Putative SUMO-1 pathway
|
40 |
0.473 |
Genes names |
- AKT Serine/Threonine Kinase 1
- AKT Serine/Threonine Kinase 2
- AKT Serine/Threonine Kinase 3
|
|
65 |
|
Crizotinib Pathway, Pharmacokinetics/Pharmacodynamics
|
38 |
0.473 |
Genes names |
- AKT Serine/Threonine Kinase 1
- AKT Serine/Threonine Kinase 2
- AKT Serine/Threonine Kinase 3
|
|
66 |
|
Development EGFR signaling pathway
|
154 |
0.473 |
Genes names |
- AKT Serine/Threonine Kinase 1
- AKT Serine/Threonine Kinase 2
- AKT Serine/Threonine Kinase 3
|
|
67 |
|
Immune response NFAT in immune response
|
162 |
0.473 |
Genes names |
- AKT Serine/Threonine Kinase 1
- AKT Serine/Threonine Kinase 2
- AKT Serine/Threonine Kinase 3
|
|
68 |
|
Immune response IL-2 activation and signaling pathway
|
75 |
0.473 |
Genes names |
- AKT Serine/Threonine Kinase 1
- AKT Serine/Threonine Kinase 2
- AKT Serine/Threonine Kinase 3
|
|
69 |
|
VEGF Signaling Pathway
|
93 |
0.473 |
Genes names |
- AKT Serine/Threonine Kinase 1
- AKT Serine/Threonine Kinase 2
- AKT Serine/Threonine Kinase 3
|
|
70 |
|
Development Dopamine D2 receptor transactivation of EGFR
|
128 |
0.473 |
Genes names |
- AKT Serine/Threonine Kinase 1
- AKT Serine/Threonine Kinase 2
- AKT Serine/Threonine Kinase 3
|
|
71 |
|
VEGF Pathway (Qiagen)
|
122 |
0.473 |
Genes names |
- AKT Serine/Threonine Kinase 1
- AKT Serine/Threonine Kinase 2
- AKT Serine/Threonine Kinase 3
|
|
72 |
|
Immune response IL-23 signaling pathway
|
160 |
0.473 |
Genes names |
- AKT Serine/Threonine Kinase 1
- AKT Serine/Threonine Kinase 2
- AKT Serine/Threonine Kinase 3
|
|
73 |
|
Prolactin Signaling
|
432 |
0.473 |
Genes names |
- AKT Serine/Threonine Kinase 1
- AKT Serine/Threonine Kinase 2
- AKT Serine/Threonine Kinase 3
|
|
74 |
|
TGF-Beta Pathway
|
653 |
0.473 |
Genes names |
- AKT Serine/Threonine Kinase 1
- AKT Serine/Threonine Kinase 2
- AKT Serine/Threonine Kinase 3
|
|
75 |
|
MAPK Pathway
|
88 |
0.473 |
Genes names |
- AKT Serine/Threonine Kinase 1
- AKT Serine/Threonine Kinase 2
- AKT Serine/Threonine Kinase 3
|
|
76 |
|
GDNF-Family Ligands and Receptor Interactions
|
100 |
0.473 |
Genes names |
- AKT Serine/Threonine Kinase 1
- AKT Serine/Threonine Kinase 2
- AKT Serine/Threonine Kinase 3
|
|
77 |
|
GPCR Pathway
|
712 |
0.473 |
Genes names |
- AKT Serine/Threonine Kinase 1
- AKT Serine/Threonine Kinase 2
- AKT Serine/Threonine Kinase 3
|
|
78 |
|
p53 Signaling
|
117 |
0.473 |
Genes names |
- AKT Serine/Threonine Kinase 1
- AKT Serine/Threonine Kinase 2
- AKT Serine/Threonine Kinase 3
|
|
79 |
|
Blood-Brain Barrier and Immune Cell Transmigration: VCAM-1/CD106 Signaling
|
104 |
0.473 |
Genes names |
- AKT Serine/Threonine Kinase 1
- AKT Serine/Threonine Kinase 2
- AKT Serine/Threonine Kinase 3
|
|
80 |
|
Regulation of TP53 Activity through Acetylation
|
30 |
0.473 |
Genes names |
- AKT Serine/Threonine Kinase 1
- AKT Serine/Threonine Kinase 2
- AKT Serine/Threonine Kinase 3
|
|
81 |
|
mTOR Pathway
|
58 |
0.473 |
Genes names |
- AKT Serine/Threonine Kinase 1
- AKT Serine/Threonine Kinase 2
- AKT Serine/Threonine Kinase 3
|
|
82 |
|
LT-BetaR Pathway
|
56 |
0.473 |
Genes names |
- AKT Serine/Threonine Kinase 1
- AKT Serine/Threonine Kinase 2
- AKT Serine/Threonine Kinase 3
|
|
83 |
|
G-protein signaling G-Protein alpha-i signaling cascades
|
210 |
0.473 |
Genes names |
- AKT Serine/Threonine Kinase 1
- AKT Serine/Threonine Kinase 2
- AKT Serine/Threonine Kinase 3
|
|
84 |
|
FOXO-mediated transcription
|
65 |
0.473 |
Genes names |
- AKT Serine/Threonine Kinase 1
- AKT Serine/Threonine Kinase 2
- AKT Serine/Threonine Kinase 3
|
|
85 |
|
Apoptosis and survival BAD phosphorylation
|
112 |
0.473 |
Genes names |
- AKT Serine/Threonine Kinase 1
- AKT Serine/Threonine Kinase 2
- AKT Serine/Threonine Kinase 3
|
|
86 |
|
Epithelial to mesenchymal transition in colorectal cancer
|
161 |
0.473 |
Genes names |
- AKT Serine/Threonine Kinase 1
- AKT Serine/Threonine Kinase 2
- AKT Serine/Threonine Kinase 3
|
|
87 |
|
NFAT and Cardiac Hypertrophy
|
326 |
0.473 |
Genes names |
- AKT Serine/Threonine Kinase 1
- AKT Serine/Threonine Kinase 2
- AKT Serine/Threonine Kinase 3
|
|
88 |
|
Sertoli-Sertoli Cell Junction Dynamics
|
393 |
0.473 |
Genes names |
- AKT Serine/Threonine Kinase 1
- AKT Serine/Threonine Kinase 2
- AKT Serine/Threonine Kinase 3
|
|
89 |
|
FLT3 signaling in disease
|
48 |
0.473 |
Genes names |
- AKT Serine/Threonine Kinase 1
- AKT Serine/Threonine Kinase 2
- AKT Serine/Threonine Kinase 3
|
|
90 |
|
Nuclear events mediated by NFE2L2
|
199 |
0.473 |
Genes names |
- AKT Serine/Threonine Kinase 1
- AKT Serine/Threonine Kinase 2
- AKT Serine/Threonine Kinase 3
|
|
91 |
|
AMPK Enzyme Complex Pathway
|
153 |
0.473 |
Genes names |
- AKT Serine/Threonine Kinase 1
- AKT Serine/Threonine Kinase 2
- AKT Serine/Threonine Kinase 3
|
|
92 |
|
Cytokine Signaling in Immune system
|
732 |
0.473 |
Genes names |
- AKT Serine/Threonine Kinase 1
- AKT Serine/Threonine Kinase 2
- AKT Serine/Threonine Kinase 3
|
|
93 |
|
Development A3 receptor signaling
|
106 |
0.473 |
Genes names |
- AKT Serine/Threonine Kinase 1
- AKT Serine/Threonine Kinase 2
- AKT Serine/Threonine Kinase 3
|
|
94 |
|
Neural crest cell migration in cancer
|
34 |
0.473 |
Genes names |
- AKT Serine/Threonine Kinase 1
- AKT Serine/Threonine Kinase 2
- AKT Serine/Threonine Kinase 3
|
|
95 |
|
Sildenafil treatment
|
21 |
0.473 |
Genes names |
- AKT Serine/Threonine Kinase 1
- AKT Serine/Threonine Kinase 2
- AKT Serine/Threonine Kinase 3
|
|
96 |
|
Apoptotic Pathways in Synovial Fibroblasts
|
731 |
0.473 |
Genes names |
- AKT Serine/Threonine Kinase 1
- AKT Serine/Threonine Kinase 2
- AKT Serine/Threonine Kinase 3
|
|
97 |
|
Signaling by VEGF
|
108 |
0.473 |
Genes names |
- AKT Serine/Threonine Kinase 1
- AKT Serine/Threonine Kinase 2
- AKT Serine/Threonine Kinase 3
|
|
98 |
|
S1P receptor signal transduction
|
25 |
0.473 |
Genes names |
- AKT Serine/Threonine Kinase 1
- AKT Serine/Threonine Kinase 2
- AKT Serine/Threonine Kinase 3
|
|
99 |
|
IL-9 Signaling Pathways
|
169 |
0.473 |
Genes names |
- AKT Serine/Threonine Kinase 1
- AKT Serine/Threonine Kinase 2
- AKT Serine/Threonine Kinase 3
|
|
100 |
|
Development FGFR signaling pathway
|
134 |
0.473 |
Genes names |
- AKT Serine/Threonine Kinase 1
- AKT Serine/Threonine Kinase 2
- AKT Serine/Threonine Kinase 3
|
|
101 |
|
Cell cycle Role of 14-3-3 proteins in cell cycle regulation
|
30 |
0.473 |
Genes names |
- AKT Serine/Threonine Kinase 1
- AKT Serine/Threonine Kinase 2
- AKT Serine/Threonine Kinase 3
|
|
102 |
|
GPCR downstream signalling
|
710 |
0.473 |
Genes names |
- AKT Serine/Threonine Kinase 1
- AKT Serine/Threonine Kinase 2
- AKT Serine/Threonine Kinase 3
|
|
103 |
|
Phospholipase-C Pathway
|
503 |
0.473 |
Genes names |
- AKT Serine/Threonine Kinase 1
- AKT Serine/Threonine Kinase 2
- AKT Serine/Threonine Kinase 3
|
|
104 |
|
Nervous system development
|
1168 |
0.473 |
Genes names |
- AKT Serine/Threonine Kinase 1
- AKT Serine/Threonine Kinase 2
- AKT Serine/Threonine Kinase 3
|
|
105 |
|
Regulation of beta-cell development
|
41 |
0.473 |
Genes names |
- AKT Serine/Threonine Kinase 1
- AKT Serine/Threonine Kinase 2
- AKT Serine/Threonine Kinase 3
|
|
106 |
|
G12-G13 in Cellular Signaling
|
123 |
0.473 |
Genes names |
- AKT Serine/Threonine Kinase 1
- AKT Serine/Threonine Kinase 2
- AKT Serine/Threonine Kinase 3
|
|
107 |
|
TP53 Regulates Metabolic Genes
|
87 |
0.473 |
Genes names |
- AKT Serine/Threonine Kinase 1
- AKT Serine/Threonine Kinase 2
- AKT Serine/Threonine Kinase 3
|
|
108 |
|
Glucose / Energy Metabolism
|
307 |
0.473 |
Genes names |
- AKT Serine/Threonine Kinase 1
- AKT Serine/Threonine Kinase 2
- AKT Serine/Threonine Kinase 3
|
|
109 |
|
Development Ligand-independent activation of ESR1 and ESR2
|
135 |
0.473 |
Genes names |
- AKT Serine/Threonine Kinase 1
- AKT Serine/Threonine Kinase 2
- AKT Serine/Threonine Kinase 3
|
|
110 |
|
Head and neck squamous cell carcinoma
|
73 |
0.473 |
Genes names |
- AKT Serine/Threonine Kinase 1
- AKT Serine/Threonine Kinase 2
- AKT Serine/Threonine Kinase 3
|
|
111 |
|
Development A2B receptor- action via G-protein alpha s
|
87 |
0.473 |
Genes names |
- AKT Serine/Threonine Kinase 1
- AKT Serine/Threonine Kinase 2
- AKT Serine/Threonine Kinase 3
|
|
112 |
|
Development Endothelin-1/EDNRA transactivation of EGFR
|
115 |
0.473 |
Genes names |
- AKT Serine/Threonine Kinase 1
- AKT Serine/Threonine Kinase 2
- AKT Serine/Threonine Kinase 3
|
|
113 |
|
Jak-Stat Signaling Pathway
|
88 |
0.473 |
Genes names |
- AKT Serine/Threonine Kinase 1
- AKT Serine/Threonine Kinase 2
- AKT Serine/Threonine Kinase 3
|
|
114 |
|
Signal Transduction
|
2590 |
0.473 |
Genes names |
- AKT Serine/Threonine Kinase 1
- AKT Serine/Threonine Kinase 2
- AKT Serine/Threonine Kinase 3
|
|
115 |
|
Immune response_IFN gamma signaling pathway
|
63 |
0.473 |
Genes names |
- AKT Serine/Threonine Kinase 1
- AKT Serine/Threonine Kinase 2
- AKT Serine/Threonine Kinase 3
|
|
116 |
|
Signal transduction_Erk Interactions- Inhibition of Erk
|
74 |
0.473 |
Genes names |
- AKT Serine/Threonine Kinase 1
- AKT Serine/Threonine Kinase 2
- AKT Serine/Threonine Kinase 3
|
|
117 |
|
Regulation of activated PAK-2p34 by proteasome mediated degradation
|
978 |
0.473 |
Genes names |
- AKT Serine/Threonine Kinase 1
- AKT Serine/Threonine Kinase 2
- AKT Serine/Threonine Kinase 3
|
|
118 |
|
G-protein beta:gamma signalling
|
32 |
0.473 |
Genes names |
- AKT Serine/Threonine Kinase 1
- AKT Serine/Threonine Kinase 2
- AKT Serine/Threonine Kinase 3
|
|
119 |
|
Focal adhesion
|
197 |
0.473 |
Genes names |
- AKT Serine/Threonine Kinase 1
- AKT Serine/Threonine Kinase 2
- AKT Serine/Threonine Kinase 3
|
|
120 |
|
Malignant pleural mesothelioma
|
409 |
0.473 |
Genes names |
- AKT Serine/Threonine Kinase 1
- AKT Serine/Threonine Kinase 2
- AKT Serine/Threonine Kinase 3
|
|
121 |
|
RAF/MAP kinase cascade
|
571 |
0.473 |
Genes names |
- AKT Serine/Threonine Kinase 1
- AKT Serine/Threonine Kinase 2
- AKT Serine/Threonine Kinase 3
|
|
122 |
|
Toll-like receptor signaling pathway
|
285 |
0.473 |
Genes names |
- AKT Serine/Threonine Kinase 1
- AKT Serine/Threonine Kinase 2
- AKT Serine/Threonine Kinase 3
|
|
123 |
|
SARS-CoV-2 Infection
|
414 |
0.473 |
Genes names |
- AKT Serine/Threonine Kinase 1
- AKT Serine/Threonine Kinase 2
- AKT Serine/Threonine Kinase 3
|
|
124 |
|
Class I MHC mediated antigen processing and presentation
|
855 |
0.473 |
Genes names |
- AKT Serine/Threonine Kinase 1
- AKT Serine/Threonine Kinase 2
- AKT Serine/Threonine Kinase 3
|
|
125 |
|
Cell Cycle, Mitotic
|
691 |
0.473 |
Genes names |
- AKT Serine/Threonine Kinase 1
- AKT Serine/Threonine Kinase 2
- AKT Serine/Threonine Kinase 3
|
|
126 |
|
Development EGFR signaling via small GTPases
|
70 |
0.473 |
Genes names |
- AKT Serine/Threonine Kinase 1
- AKT Serine/Threonine Kinase 2
- AKT Serine/Threonine Kinase 3
|
|
127 |
|
Activation of cAMP-Dependent PKA
|
632 |
0.473 |
Genes names |
- AKT Serine/Threonine Kinase 1
- AKT Serine/Threonine Kinase 2
- AKT Serine/Threonine Kinase 3
|
|
128 |
|
Infectious disease
|
1747 |
0.473 |
Genes names |
- AKT Serine/Threonine Kinase 1
- AKT Serine/Threonine Kinase 2
- AKT Serine/Threonine Kinase 3
|
|
129 |
|
ESR-mediated signaling
|
298 |
0.473 |
Genes names |
- AKT Serine/Threonine Kinase 1
- AKT Serine/Threonine Kinase 2
- AKT Serine/Threonine Kinase 3
|
|
130 |
|
Innate Immune System
|
2025 |
0.473 |
Genes names |
- AKT Serine/Threonine Kinase 1
- AKT Serine/Threonine Kinase 2
- AKT Serine/Threonine Kinase 3
|
|
131 |
|
Intrinsic Pathway for Apoptosis
|
55 |
0.473 |
Genes names |
- AKT Serine/Threonine Kinase 1
- AKT Serine/Threonine Kinase 2
- AKT Serine/Threonine Kinase 3
|
|
132 |
|
G-Beta Gamma Signaling
|
219 |
0.473 |
Genes names |
- AKT Serine/Threonine Kinase 1
- AKT Serine/Threonine Kinase 2
- AKT Serine/Threonine Kinase 3
|
|
133 |
|
Human Embryonic Stem Cell Pluripotency
|
186 |
0.473 |
Genes names |
- AKT Serine/Threonine Kinase 1
- AKT Serine/Threonine Kinase 2
- AKT Serine/Threonine Kinase 3
|
|
134 |
|
Signaling by ERBB2
|
50 |
0.473 |
Genes names |
- AKT Serine/Threonine Kinase 1
- AKT Serine/Threonine Kinase 2
- AKT Serine/Threonine Kinase 3
|
|
135 |
|
Regulation of TP53 Expression and Degradation
|
37 |
0.473 |
Genes names |
- AKT Serine/Threonine Kinase 1
- AKT Serine/Threonine Kinase 2
- AKT Serine/Threonine Kinase 3
|
|
136 |
|
Transcription Androgen Receptor nuclear signaling
|
98 |
0.473 |
Genes names |
- AKT Serine/Threonine Kinase 1
- AKT Serine/Threonine Kinase 2
- AKT Serine/Threonine Kinase 3
|
|
137 |
|
G-AlphaQ Signaling
|
216 |
0.473 |
Genes names |
- AKT Serine/Threonine Kinase 1
- AKT Serine/Threonine Kinase 2
- AKT Serine/Threonine Kinase 3
|
|
138 |
|
Ras signaling
|
183 |
0.473 |
Genes names |
- AKT Serine/Threonine Kinase 1
- AKT Serine/Threonine Kinase 2
- AKT Serine/Threonine Kinase 3
|
|
139 |
|
Immune response Function of MEF2 in T lymphocytes
|
124 |
0.473 |
Genes names |
- AKT Serine/Threonine Kinase 1
- AKT Serine/Threonine Kinase 2
- AKT Serine/Threonine Kinase 3
|
|
140 |
|
GDNF signaling
|
132 |
0.386 |
Genes names |
- AKT Serine/Threonine Kinase 1
- AKT Serine/Threonine Kinase 3
|
|
141 |
|
Angiopoietin-like protein 8 regulatory pathway
|
194 |
0.386 |
Genes names |
- AKT Serine/Threonine Kinase 1
- AKT Serine/Threonine Kinase 2
|
|
142 |
|
Activation of AMPK downstream of NMDARs
|
84 |
0.386 |
Genes names |
- AKT Serine/Threonine Kinase 1
- AKT Serine/Threonine Kinase 2
|
|
143 |
|
Insulin-mediated glucose transport
|
19 |
0.386 |
Genes names |
- AKT Serine/Threonine Kinase 1
- AKT Serine/Threonine Kinase 2
|
|
144 |
|
S1P3 pathway
|
15 |
0.386 |
Genes names |
- AKT Serine/Threonine Kinase 1
- AKT Serine/Threonine Kinase 3
|
|
145 |
|
Kisspeptin/kisspeptin receptor system in the ovary
|
39 |
0.386 |
Genes names |
- AKT Serine/Threonine Kinase 1
- AKT Serine/Threonine Kinase 2
|
|
146 |
|
MicroRNAs in cardiomyocyte hypertrophy
|
112 |
0.386 |
Genes names |
- AKT Serine/Threonine Kinase 1
- AKT Serine/Threonine Kinase 2
|
|
147 |
|
MTOR signalling
|
55 |
0.386 |
Genes names |
- AKT Serine/Threonine Kinase 1
- AKT Serine/Threonine Kinase 2
|
|
148 |
|
Signaling by WNT
|
331 |
0.386 |
Genes names |
- AKT Serine/Threonine Kinase 1
- AKT Serine/Threonine Kinase 2
|
|
149 |
|
Insulin Pathway
|
44 |
0.386 |
Genes names |
- AKT Serine/Threonine Kinase 1
- AKT Serine/Threonine Kinase 2
|
|
150 |
|
BDNF-TrkB signaling
|
46 |
0.386 |
Genes names |
- AKT Serine/Threonine Kinase 1
- AKT Serine/Threonine Kinase 3
|
|
151 |
|
Transcription factors regulate miRNAs related to cardiac hypertrophy
|
9 |
0.386 |
Genes names |
- AKT Serine/Threonine Kinase 1
- AKT Serine/Threonine Kinase 2
|
|
152 |
|
Deactivation of the beta-catenin transactivating complex
|
42 |
0.386 |
Genes names |
- AKT Serine/Threonine Kinase 1
- AKT Serine/Threonine Kinase 2
|
|
153 |
|
PDGFR-beta signaling pathway
|
146 |
0.273 |
Genes names |
- AKT Serine/Threonine Kinase 1
|
|
154 |
|
Regulation of apoptosis by parathyroid hormone-related protein
|
22 |
0.273 |
Genes names |
- AKT Serine/Threonine Kinase 1
|
|
155 |
|
Pathways affected in adenoid cystic carcinoma
|
62 |
0.273 |
Genes names |
- AKT Serine/Threonine Kinase 1
|
|
156 |
|
CREB Pathway
|
529 |
0.273 |
Genes names |
- AKT Serine/Threonine Kinase 1
|
|
157 |
|
Endochondral ossification with skeletal dysplasias
|
63 |
0.273 |
Genes names |
- AKT Serine/Threonine Kinase 1
|
|
158 |
|
Gastrin signaling pathway
|
112 |
0.273 |
Genes names |
- AKT Serine/Threonine Kinase 1
|
|
159 |
|
IL2 signaling events mediated by STAT5
|
74 |
0.273 |
Genes names |
- AKT Serine/Threonine Kinase 1
|
|
160 |
|
Signaling events mediated by the Hedgehog family
|
24 |
0.273 |
Genes names |
- AKT Serine/Threonine Kinase 1
|
|
161 |
|
Reelin signaling pathway
|
28 |
0.273 |
Genes names |
- AKT Serine/Threonine Kinase 1
|
|
162 |
|
Insulin receptor signalling cascade
|
87 |
0.273 |
Genes names |
- AKT Serine/Threonine Kinase 2
|
|
163 |
|
Physico-chemical features and toxicity-associated pathways
|
65 |
0.273 |
Genes names |
- AKT Serine/Threonine Kinase 1
|
|
164 |
|
Apoptosis-related network due to altered Notch3 in ovarian cancer
|
52 |
0.273 |
Genes names |
- AKT Serine/Threonine Kinase 1
|
|
165 |
|
Aurora A signaling
|
33 |
0.273 |
Genes names |
- AKT Serine/Threonine Kinase 1
|
|
166 |
|
Clear cell renal cell carcinoma pathways
|
85 |
0.273 |
Genes names |
- AKT Serine/Threonine Kinase 1
|
|
167 |
|
ErbB2/ErbB3 signaling events
|
32 |
0.273 |
Genes names |
- AKT Serine/Threonine Kinase 1
|
|
168 |
|
Host-pathogen interaction of human coronaviruses - apoptosis
|
21 |
0.273 |
Genes names |
- AKT Serine/Threonine Kinase 1
|
|
169 |
|
Estrogen signaling pathway
|
23 |
0.273 |
Genes names |
- AKT Serine/Threonine Kinase 1
|
|
170 |
|
Wnt/beta-catenin signaling pathway in leukemia
|
24 |
0.273 |
Genes names |
- AKT Serine/Threonine Kinase 1
|
|
171 |
|
Microtubule cytoskeleton regulation
|
46 |
0.273 |
Genes names |
- AKT Serine/Threonine Kinase 1
|
|
172 |
|
Acute viral myocarditis
|
75 |
0.273 |
Genes names |
- AKT Serine/Threonine Kinase 1
|
|
173 |
|
a6b1 and a6b4 Integrin signaling
|
37 |
0.273 |
Genes names |
- AKT Serine/Threonine Kinase 1
|
|
174 |
|
IGF1 pathway
|
29 |
0.273 |
Genes names |
- AKT Serine/Threonine Kinase 1
|
|
175 |
|
FGF signaling pathway
|
54 |
0.273 |
Genes names |
- AKT Serine/Threonine Kinase 1
|
|
176 |
|
Leptin-insulin signaling overlap
|
21 |
0.273 |
Genes names |
- AKT Serine/Threonine Kinase 1
|
|
177 |
|
VEGFR3 signaling in lymphatic endothelium
|
24 |
0.273 |
Genes names |
- AKT Serine/Threonine Kinase 1
|
|
178 |
|
Ovarian infertility
|
36 |
0.273 |
Genes names |
- AKT Serine/Threonine Kinase 1
|
|
179 |
|
IL4-mediated signaling events
|
60 |
0.273 |
Genes names |
- AKT Serine/Threonine Kinase 1
|
|
180 |
|
Nanog in Mammalian ESC Pluripotency
|
534 |
0.273 |
Genes names |
- AKT Serine/Threonine Kinase 1
|
|
181 |
|
Primary focal segmental glomerulosclerosis (FSGS)
|
72 |
0.273 |
Genes names |
- AKT Serine/Threonine Kinase 1
|
|
182 |
|
E-cadherin signaling in the nascent adherens junction
|
35 |
0.273 |
Genes names |
- AKT Serine/Threonine Kinase 1
|
|
183 |
|
Insulin signaling in adipocytes (normal condition)
|
8 |
0.273 |
Genes names |
- AKT Serine/Threonine Kinase 2
|
|
184 |
|
Extracellular vesicle-mediated signaling in recipient cells
|
28 |
0.273 |
Genes names |
- AKT Serine/Threonine Kinase 1
|
|
185 |
|
MIF Mediated Glucocorticoid Regulation
|
681 |
0.273 |
Genes names |
- AKT Serine/Threonine Kinase 1
|
|
186 |
|
3q29 copy number variation syndrome
|
62 |
0.273 |
Genes names |
- AKT Serine/Threonine Kinase 1
|
|
187 |
|
Integrin-linked kinase signaling
|
46 |
0.273 |
Genes names |
- AKT Serine/Threonine Kinase 1
|
|
188 |
|
CXCR4-mediated signaling events
|
57 |
0.273 |
Genes names |
- AKT Serine/Threonine Kinase 1
|
|
189 |
|
Fc-GammaR Pathway
|
84 |
0.273 |
Genes names |
- AKT Serine/Threonine Kinase 1
|
|
190 |
|
Angiogenesis (WikiPathways)
|
19 |
0.273 |
Genes names |
- AKT Serine/Threonine Kinase 1
|
|
191 |
|
Network map of SARS-CoV-2 signaling pathway
|
48 |
0.273 |
Genes names |
- AKT Serine/Threonine Kinase 1
|
|
192 |
|
IL8- and CXCR2-mediated signaling events
|
31 |
0.273 |
Genes names |
- AKT Serine/Threonine Kinase 1
|
|
193 |
|
FoxO family signaling
|
31 |
0.273 |
Genes names |
- AKT Serine/Threonine Kinase 1
|
|
194 |
|
NF-KappaB Family Pathway
|
242 |
0.273 |
Genes names |
- AKT Serine/Threonine Kinase 1
|
|
195 |
|
TCR signaling in naïve CD4+ T cells
|
65 |
0.273 |
Genes names |
- AKT Serine/Threonine Kinase 1
|
|
196 |
|
TNF Superfamily - Human Ligand-Receptor Interactions and their Associated Functions
|
170 |
0.273 |
Genes names |
- AKT Serine/Threonine Kinase 1
|
|
197 |
|
PKB-mediated events
|
2 |
0.273 |
Genes names |
- AKT Serine/Threonine Kinase 2
|
|
198 |
|
FOXA2 and FOXA3 transcription factor networks
|
40 |
0.273 |
Genes names |
- AKT Serine/Threonine Kinase 1
|
|
199 |
|
Dravet syndrome
|
30 |
0.273 |
Genes names |
- AKT Serine/Threonine Kinase 1
|
|
200 |
|
Thromboxane A2 receptor signaling
|
34 |
0.273 |
Genes names |
- AKT Serine/Threonine Kinase 1
|
|
201 |
|
E-cadherin signaling in keratinocytes
|
18 |
0.273 |
Genes names |
- AKT Serine/Threonine Kinase 1
|
|
202 |
|
Celecoxib Pathway, Pharmacodynamics
|
58 |
0.273 |
Genes names |
- AKT Serine/Threonine Kinase 1
|
|
203 |
|
p70S6K Signaling
|
392 |
0.273 |
Genes names |
- AKT Serine/Threonine Kinase 1
|
|
204 |
|
T-cell activation SARS-CoV-2
|
116 |
0.273 |
Genes names |
- AKT Serine/Threonine Kinase 1
|
|
205 |
|
Somatroph axis (GH) and its relationship to dietary restriction and aging
|
5 |
0.273 |
Genes names |
- AKT Serine/Threonine Kinase 1
|
|
206 |
|
Neovascularisation processes
|
34 |
0.273 |
Genes names |
- AKT Serine/Threonine Kinase 1
|
|
207 |
|
Metabolism of steroids
|
194 |
0.273 |
Genes names |
- AKT Serine/Threonine Kinase 1
|
|
208 |
|
Primary ovarian insufficiency
|
170 |
0.273 |
Genes names |
- AKT Serine/Threonine Kinase 1
|
|
209 |
|
Caloric restriction and aging
|
9 |
0.273 |
Genes names |
- AKT Serine/Threonine Kinase 1
|
|
210 |
|
CASP8 activity is inhibited
|
57 |
0.273 |
Genes names |
- AKT Serine/Threonine Kinase 1
|
|
211 |
|
Neuroinflammation and glutamatergic signaling
|
140 |
0.273 |
Genes names |
- AKT Serine/Threonine Kinase 1
|
|
212 |
|
Metabolism of cofactors
|
21 |
0.273 |
Genes names |
- AKT Serine/Threonine Kinase 1
|
|
213 |
|
Thyroid stimulating hormone (TSH) signaling pathway
|
58 |
0.273 |
Genes names |
- AKT Serine/Threonine Kinase 1
|
|
214 |
|
Interleukin-11 signaling pathway
|
44 |
0.273 |
Genes names |
- AKT Serine/Threonine Kinase 1
|
|
215 |
|
Roles of ceramides in development of insulin resistance
|
22 |
0.273 |
Genes names |
- AKT Serine/Threonine Kinase 1
|
|
216 |
|
Fragile X syndrome
|
120 |
0.273 |
Genes names |
- AKT Serine/Threonine Kinase 1
|
|
217 |
|
LPA receptor mediated events
|
47 |
0.273 |
Genes names |
- AKT Serine/Threonine Kinase 1
|
|
218 |
|
Integrins in angiogenesis
|
57 |
0.273 |
Genes names |
- AKT Serine/Threonine Kinase 1
|
|
219 |
|
Thyroid hormones production and peripheral downstream signaling effects
|
83 |
0.273 |
Genes names |
- AKT Serine/Threonine Kinase 3
|
|
220 |
|
CKAP4 signaling pathway map
|
108 |
0.273 |
Genes names |
- AKT Serine/Threonine Kinase 1
|
|
221 |
|
TNFR1 Pathway
|
190 |
0.273 |
Genes names |
- AKT Serine/Threonine Kinase 1
|
|
222 |
|
Development EPO-induced Jak-STAT pathway
|
75 |
0.273 |
Genes names |
- AKT Serine/Threonine Kinase 1
|
|
223 |
|
TGF-beta signaling in thyroid cells for epithelial-mesenchymal transition
|
14 |
0.273 |
Genes names |
- AKT Serine/Threonine Kinase 1
|
|
224 |
|
Response to elevated platelet cytosolic Ca2+
|
621 |
0.273 |
Genes names |
- AKT Serine/Threonine Kinase 1
|
|
225 |
|
IL-17 Family Signaling Pathways
|
108 |
0.273 |
Genes names |
- AKT Serine/Threonine Kinase 1
|
|
226 |
|
Integrin Pathway
|
570 |
0.273 |
Genes names |
- AKT Serine/Threonine Kinase 1
|
|
227 |
|
Nongenotropic Androgen signaling
|
18 |
0.273 |
Genes names |
- AKT Serine/Threonine Kinase 1
|
|
228 |
|
14-3-3 and Regulation of BAD Activity
|
32 |
0.273 |
Genes names |
- AKT Serine/Threonine Kinase 1
|
|
229 |
|
Metabolism of water-soluble vitamins and cofactors
|
191 |
0.273 |
Genes names |
- AKT Serine/Threonine Kinase 1
|
|
230 |
|
Ceramide Pathway
|
93 |
0.273 |
Genes names |
- AKT Serine/Threonine Kinase 1
|
|
231 |
|
CNTF Signaling
|
149 |
0.273 |
Genes names |
- AKT Serine/Threonine Kinase 1
|
|
232 |
|
Pre-NOTCH Expression and Processing
|
235 |
0.273 |
Genes names |
- AKT Serine/Threonine Kinase 1
|
|
233 |
|
Hedgehog signaling events mediated by Gli proteins
|
38 |
0.273 |
Genes names |
- AKT Serine/Threonine Kinase 1
|
|
234 |
|
Interleukin-4 and Interleukin-13 signaling
|
108 |
0.273 |
Genes names |
- AKT Serine/Threonine Kinase 1
|
|
235 |
|
Integrated breast cancer pathway
|
150 |
0.273 |
Genes names |
- AKT Serine/Threonine Kinase 1
|
|
236 |
|
p75(NTR)-mediated signaling
|
61 |
0.273 |
Genes names |
- AKT Serine/Threonine Kinase 1
|
|
237 |
|
Processing of Capped Intron-Containing Pre-mRNA
|
745 |
0.273 |
Genes names |
- AKT Serine/Threonine Kinase 1
|
|
238 |
|
T cell receptor and co-stimulatory signaling
|
26 |
0.273 |
Genes names |
- AKT Serine/Threonine Kinase 1
|
|
239 |
|
Plasma membrane estrogen receptor signaling
|
24 |
0.273 |
Genes names |
- AKT Serine/Threonine Kinase 1
|
|
240 |
|
Retinoic acid receptors-mediated signaling
|
24 |
0.273 |
Genes names |
- AKT Serine/Threonine Kinase 1
|
|
241 |
|
Copper homeostasis
|
51 |
0.273 |
Genes names |
- AKT Serine/Threonine Kinase 1
|
|
242 |
|
Ebola virus infection in host
|
129 |
0.273 |
Genes names |
- AKT Serine/Threonine Kinase 1
|
|
243 |
|
Kallmann syndrome
|
21 |
0.273 |
Genes names |
- AKT Serine/Threonine Kinase 1
|
|
244 |
|
Metabolism
|
2121 |
0.273 |
Genes names |
- AKT Serine/Threonine Kinase 1
|
|
245 |
|
MECP2 and associated Rett syndrome
|
73 |
0.273 |
Genes names |
- AKT Serine/Threonine Kinase 1
|
|
246 |
|
miRNA regulation of DNA damage response
|
74 |
0.273 |
Genes names |
- AKT Serine/Threonine Kinase 1
|
|
247 |
|
Signaling events mediated by PTP1B
|
46 |
0.273 |
Genes names |
- AKT Serine/Threonine Kinase 1
|
|
248 |
|
Mammary gland development pathway - Embryonic development (Stage 1 of 4)
|
18 |
0.273 |
Genes names |
- AKT Serine/Threonine Kinase 1
|
|
249 |
|
Gemtuzumab ozogamicin Pathway, Pharmacokinetics/Pharmacodynamics
|
23 |
0.273 |
Genes names |
- AKT Serine/Threonine Kinase 1
|
|
250 |
|
Anti-diabetic Drug Potassium Channel Inhibitors Pathway, Pharmacodynamics
|
28 |
0.273 |
Genes names |
- AKT Serine/Threonine Kinase 1
|
|
251 |
|
Endothelins
|
32 |
0.273 |
Genes names |
- AKT Serine/Threonine Kinase 1
|
|
252 |
|
Regulation of Telomerase
|
68 |
0.273 |
Genes names |
- AKT Serine/Threonine Kinase 1
|
|
253 |
|
HIF-1-alpha transcription factor network
|
65 |
0.273 |
Genes names |
- AKT Serine/Threonine Kinase 1
|
|
254 |
|
Congenital generalized lipodystrophy
|
17 |
0.273 |
Genes names |
- AKT Serine/Threonine Kinase 2
|
|
255 |
|
BCR signaling pathway
|
65 |
0.273 |
Genes names |
- AKT Serine/Threonine Kinase 1
|
|
256 |
|
4-hydroxytamoxifen, dexamethasone, and retinoic acids regulation of p27 expression
|
17 |
0.273 |
Genes names |
- AKT Serine/Threonine Kinase 1
|
|
257 |
|
Resolvin E1 and resolvin D1 signaling pathways promoting inflammation resolution
|
12 |
0.273 |
Genes names |
- AKT Serine/Threonine Kinase 1
|
|
258 |
|
Clock-controlled autophagy in bone metabolism
|
80 |
0.273 |
Genes names |
- AKT Serine/Threonine Kinase 1
|
|
259 |
|
Glucocorticoid receptor regulatory network
|
77 |
0.273 |
Genes names |
- AKT Serine/Threonine Kinase 1
|
|
260 |
|
Class I PI3K signaling events
|
29 |
0.273 |
Genes names |
- AKT Serine/Threonine Kinase 1
|
|
261 |
|
Urotensin-II-mediated signaling pathway
|
45 |
0.273 |
Genes names |
- AKT Serine/Threonine Kinase 1
|
|
262 |
|
Overview of nanoparticle effects
|
19 |
0.273 |
Genes names |
- AKT Serine/Threonine Kinase 3
|
|
263 |
|
IL6-mediated signaling events
|
45 |
0.273 |
Genes names |
- AKT Serine/Threonine Kinase 1
|
|
264 |
|
Netrin-UNC5B signaling pathway
|
52 |
0.273 |
Genes names |
- AKT Serine/Threonine Kinase 1
|
|
265 |
|
Burn wound healing
|
75 |
0.273 |
Genes names |
- AKT Serine/Threonine Kinase 1
|
|
266 |
|
CD40/CD40L signaling
|
28 |
0.273 |
Genes names |
- AKT Serine/Threonine Kinase 1
|
|
267 |
|
CXCR3-mediated signaling events
|
28 |
0.273 |
Genes names |
- AKT Serine/Threonine Kinase 1
|
|
268 |
|
Regulation of nuclear SMAD2/3 signaling
|
74 |
0.273 |
Genes names |
- AKT Serine/Threonine Kinase 1
|
|
269 |
|
IFN-gamma pathway
|
31 |
0.273 |
Genes names |
- AKT Serine/Threonine Kinase 1
|
|
270 |
|
Perturbations to host-cell autophagy, induced by SARS-CoV-2 proteins
|
18 |
0.273 |
Genes names |
- AKT Serine/Threonine Kinase 1
|
|
271 |
|
Proton Pump Inhibitor Pathway, Pharmacodynamics
|
45 |
0.273 |
Genes names |
- AKT Serine/Threonine Kinase 3
|
|
272 |
|
Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met)
|
71 |
0.273 |
Genes names |
- AKT Serine/Threonine Kinase 1
|
|
273 |
|
Metabolism of nitric oxide: NOS3 activation and regulation
|
17 |
0.273 |
Genes names |
- AKT Serine/Threonine Kinase 1
|
|
274 |
|
Coregulation of Androgen receptor activity
|
61 |
0.273 |
Genes names |
- AKT Serine/Threonine Kinase 1
|
|
275 |
|
Nephrin/Neph1 signaling in the kidney podocyte
|
23 |
0.273 |
Genes names |
- AKT Serine/Threonine Kinase 1
|
|
276 |
|
p53 pathway
|
50 |
0.273 |
Genes names |
- AKT Serine/Threonine Kinase 1
|
|
277 |
|
Signaling by PTK6
|
54 |
0.273 |
Genes names |
- AKT Serine/Threonine Kinase 1
|
|
278 |
|
Integrin signaling
|
39 |
0.273 |
Genes names |
- AKT Serine/Threonine Kinase 1
|
|
279 |
|
4-1BB Pathway
|
173 |
0.273 |
Genes names |
- AKT Serine/Threonine Kinase 1
|
|
280 |
|
VEGFR1 specific signals
|
25 |
0.273 |
Genes names |
- AKT Serine/Threonine Kinase 1
|
|
281 |
|
Fibrin complement receptor 3 signaling pathway
|
43 |
0.273 |
Genes names |
- AKT Serine/Threonine Kinase 1
|
|
282 |
|
Androgen receptor network in prostate cancer
|
105 |
0.273 |
Genes names |
- AKT Serine/Threonine Kinase 1
|
|
283 |
|
Signaling events mediated by VEGFR1 and VEGFR2
|
63 |
0.273 |
Genes names |
- AKT Serine/Threonine Kinase 1
|
|
284 |
|
Colorectal Cancer Metastasis
|
165 |
0.273 |
Genes names |
- AKT Serine/Threonine Kinase 1
|
|
285 |
|
Hepatitis C and hepatocellular carcinoma
|
55 |
0.273 |
Genes names |
- AKT Serine/Threonine Kinase 1
|
|
286 |
|
Corticotropin-releasing hormone signaling pathway
|
91 |
0.273 |
Genes names |
- AKT Serine/Threonine Kinase 1
|
|
287 |
|
Regucalcin in proximal tubule epithelial kidney cells
|
22 |
0.273 |
Genes names |
- AKT Serine/Threonine Kinase 1
|
|
288 |
|
S-1P Stimulated Signaling
|
96 |
0.273 |
Genes names |
- AKT Serine/Threonine Kinase 1
|
|
289 |
|
ADORA2B mediated anti-inflammatory cytokines production
|
419 |
0.273 |
Genes names |
- AKT Serine/Threonine Kinase 1
|
|
290 |
|
mTOR signaling pathway
|
48 |
0.273 |
Genes names |
- AKT Serine/Threonine Kinase 1
|
|